Abstract
Antisense technology was developed to inhibit gene expression by utilizing an oligonucleotide complementary to the mRNA which encodes the target gene. There are a few possible mechanisms for the inhibitory effects of antisense oligonucleotides. Among them, degradation of mRNA by RNase H is considered to be the major mechanism of action for antisense oligonucleotides. This technique was originally used to elucidate the function of a target gene, but may also have therapeutic applications, provided it is designed carefully and properly.
Original language | English |
---|---|
Pages (from-to) | 84-88 |
Number of pages | 5 |
Journal | Experimental Nephrology |
Volume | 6 |
Issue number | 1 |
Publication status | Published - Mar 13 1998 |
Keywords
- Antisense oligonucleotides
- Gene therapy
- Liposomes
ASJC Scopus subject areas
- Nephrology